Morbiditatea prin hepatita virală B şi rezultatele combaterii ei în Republica Moldova
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
826 2
Ultima descărcare din IBN:
2020-02-25 17:31
SM ISO690:2012
IAROVOI, Petru. Morbiditatea prin hepatita virală B şi rezultatele combaterii ei în Republica Moldova. In: Curierul Medical, 2013, nr. 5(56), pp. 36-40. ISSN 1875-0666.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Curierul Medical
Numărul 5(56) / 2013 / ISSN 1875-0666

Morbiditatea prin hepatita virală B şi rezultatele combaterii ei în Republica Moldova

Pag. 36-40

Iarovoi Petru
 
Centrul Naţional de Sanătate Publică
 
 
Disponibil în IBN: 10 martie 2014


Rezumat

Viral hepatitis B remain to be a global, social and medical problem, including for the Republic of Moldova, where the morbidity due to this infection is higher in comparison with other countries in Europe. This article discusses the results of the preventive measures, especially vaccination, for viral hepatitis B, taken during the last years. In the prevaccination period the number of cases registered annually among children of 0-2 years old vary from 419 in 1986 to 296 in 1989 (the year of the start of the incomplete selective vaccination), while the index of morbidity vary respectively from 1,6o/oo up to 1,2o/oo. The annual average number in the prevaccination period amounted to 343 cases and the incidence rate – to 1,38o/oo. The index of the morbidity in the second period decreased respectively from 1,1o/oo to 0,62o/oo. The average number of the reported cases in this period amounted to 150, and the morbidity rate – to 0,71o/oo. Due to the absence of the vaccine the newborn children resumed getting the universal vaccination only in the autumn of 1994. In the third period the incidence decreased from 70 cases in 1995 (the year of the start of total complete vaccination) to 2 cases in 2006. The indices of the morbidity in this period were, respectively, 0,39o/oo and 0,02o/oo. The annual average number was 14 cases, and the index of morbidity – 0,11o/oo. Thus, we can conclude that the vaccination of newborns and other risk groups is a very effective preventive measure and its further realization as well as nonspecific preventive measures will contribute from year to year to a significant reduction of the morbidity, and to the replacement of the current generation highly affected by the virus HB by another generation little affected by it.

Cuvinte-cheie
viral hepatitis B, vaccination, morbidity.